Stay updated on TAA-Specific CTLs in Pancreatic Cancer Clinical Trial
Sign up to get notified when there's something new on the TAA-Specific CTLs in Pancreatic Cancer Clinical Trial page.

Latest updates to the TAA-Specific CTLs in Pancreatic Cancer Clinical Trial page
- Check6 days agoChange DetectedThe footer revision label changes from v3.7.2 to v3.8.0; the page still displays a 403 Forbidden error instead of the study record.SummaryDifference0.2%

- Check13 days agoChange DetectedA site-wide notice about NIH’s terminology transition from “Artificial Intelligence” to “Super Intelligence” appears above the study record page.SummaryDifference1%

- Check20 days agoChange DetectedThe site footer revision identifier changed from v3.7.1 to v3.7.2 while the page continued to display a 403 access-denied error.SummaryDifference0.2%

- Check27 days agoChange DetectedThe displayed site revision changes from v3.7.0 to v3.7.1. The study page continues to show a 403 Forbidden error.SummaryDifference0.2%

- Check34 days agoChange DetectedA 403 Forbidden message appears in the study record area, with a Home link; the study details are not shown.SummaryDifference0.5%

- Check48 days agoChange DetectedThe page now shows a 403 Forbidden error, replacing the expected study record content. Access to the NCT03192462 record is blocked, preventing viewing the study details.SummaryDifference19%

Stay in the know with updates to TAA-Specific CTLs in Pancreatic Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the TAA-Specific CTLs in Pancreatic Cancer Clinical Trial page.